Article
Expert Opinion for Defining a Severe Bleeding Phenotype to Guide Prophylaxis in Patients with Nonsevere Hemophilia.
Hamostaseologie - 1 Jun 2026
Pfrepper Christian, Ettingshausen Carmen Escuriola, Klamroth Robert, Oldenburg Johannes, Olivieri Martin
Abstract excerpt
Abstract: Prophylaxis is the standard of care for patients with severe hemophilia, patients with moderate hemophilia, or those with another congenital bleeding disorder that is associated with a severe bleeding phenotype and/or a high risk of spontaneous life-threatening bleeding. Patients with nonsevere hemophilia (factor VIII [FVIII] ≥ 1%) may also have a bleeding phenotype that requires prophylaxis. To date,...
Topics
Join the communities discussing this publication.
